Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04576130

A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation

Led by Rigshospitalet, Denmark · Updated on 2025-01-27

1200

Participants Needed

1

Research Sites

624 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.

CONDITIONS

Official Title

A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with coronary artery disease and cardiac arrest due to ventricular fibrillation or sustained ventricular tachycardia, who underwent angiogram with complete revascularization (PCI, CABG, or hybrid coronary revascularization) before ICD implantation
  • Age 18 years or older
  • Left ventricular ejection fraction (LVEF) greater than 35% at the time of discharge, based on the most recent assessment
Not Eligible

You will not qualify if you...

  • Cardiac arrest due to non-ischemic causes (such as ion channel diseases or non-ischemic cardiomyopathy)
  • Previous coronary artery bypass graft (CABG) surgery within 3 months before the current hospitalization
  • Life expectancy less than 1 year or severe neurological damage
  • Unable or unwilling to give informed consent
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

Actively Recruiting

Loading map...

Research Team

R

Reza Jabbari, MD, PhD

CONTACT

T

Thomas Engstrøm, MD, PhD, DMSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here